|
Novel Use of Apple Watch 4 to Obtain 3-Lead Electrocardiogram and Detect Cardiac IschemiaCesar O Avila, MD1 Perm J 2019;23:19-025 [Full Citation] https://doi.org/10.7812/TPP/19-025E-pub: 06/27/2019ABSTRACTBackground: Early recognition and treatment of ST-elevation myocardial infarction (STEMI) results in better outcomes. INTRODUCTIONOne in 4 people die of heart disease in the US.1 Urgent revascularization is indicated in patients with ST-elevation myocardial infarction (STEMI), and earlier treatment reduces morbidity and mortality.2 Multiple barriers have been identified in preventing the early recognition of STEMI, including preexisting bias of symptoms, incorrect rationale, attribution to other medical conditions, and lack of awareness of the importance of rapid treatment.3-5 There are educational recommendations for health care practitioners, patients, and family to receive information about acute myocardial infarction to improve on treatment delays.6,7 Extending the availability of electrocardiograms (ECGs) could lead to earlier recognition and prompt treatment of acute coronary artery disease. Millions of people own the Apple Watch 4 (Apple Inc, Cupertino, CA), which can perform a single-lead ECG.8,9 Inadvertently, I noted the watch’s ECG lead reversal when wearing the watch on the right wrist instead of the left. Subsequently, I tested the watch’s capability to create a 3-lead ECG by adjusting the positioning of the watch using the Einthoven triangle as a guide. The watch has electrodes built into the digital crown (negative) and the back crystal (positive) to detect cardiac electrical signals. Lead I can be obtained using the watch as intended: Wearing the watch on the left wrist and the right index finger touching the digital crown. However, leads II and III can also be obtained by placing the positive electrode (back of the watch) against the midabdomen and using the negative electrode (digital crown) with the right or left index finger (Figure 1). METHODSBy adjusting the use of the Apple Watch 4, as shown in Figure 1, a 3-lead ECG can be obtained. These lead tracings were confirmed in control participants (Figure 2). Additionally, the watch’s 3-lead ECG was tested in 2 patients to determine concordance with ECGs showing STEMI. RESULTSCase 1A 52-year-old man presented to the Emergency Department with chest pain. He reported that his symptoms started “fairly quickly” with 9 of 10 epigastric and retrosternal chest pressure. He reported a history of back pain, but this episode was “much worse than usual” and involved his chest. On presentation, his ECG revealed a STEMI. There was notable ST-segment elevation in leads III/aVF with reciprocal changes including ST-segment depression I/aVL (Figure 3). Results of the initial laboratory studies were notable for an elevated troponin level. The patient was treated for acute coronary syndrome. While the patient was awaiting transport to the cardiac catheterization laboratory, I obtained informed consent to perform a 3-lead ECG with the Apple Watch 4 to determine concordance of its leads against the patient’s STEMI-demonstrating ECG (Figure 4). The real-time, watch-based, 3-lead ECG tracing matched the traditional ECG waveforms. Cardiac catheterization revealed severe, 100% occlusion at the ostium of the right posterolateral branch of the dominant right coronary artery. Case 2A 68-year-old man arrived at the Emergency Department with chest pain. His symptoms started while working in the yard. He described the pain as pressure with associated nausea and vomiting. On presentation, his ECG also revealed a STEMI with notable ST-segment elevation in lead III/aVF and reciprocal ST-segment depressions in lead I/aVL (Figure 5). He was treated for acute coronary syndrome. I obtained informed consent to perform a 3-lead ECG with the Apple Watch 4 to determine concordance against the patient’s ECG demonstrating STEMI (Figure 6). The real-time, watch-based, 3-lead ECG tracing matched the traditional ECG waveforms. Cardiac catheterization revealed severe, 100% occlusion of the right coronary artery. DISCUSSION In these selected cases, the 3-lead ECG tracings obtained from the Apple Watch 4 matched the waveforms of the traditional ECGs demonstrating STEMI, confirming the potential ability of this smart watch to uncover myocardial ischemia. Recent innovations in mobile health care technologies are disrupting traditional medical practice. Numerous publications reveal the use of these devices in early detection of arrhythmias, heart blocks, and cardiac ischemia.10-12 With this new watch function, the potential early detection of cardiac ischemia may permit earlier lifesaving intervention that could have a major impact on morbidity and mortality. The Apple Watch 4 reports a 98.3% sensitivity in atrial fibrillation detection.9 However, the sensitivity and specificity of the watch’s 3-lead ECG to detect cardiac ischemia are yet to be determined. The watch is also currently limited by an inability to detect precordial leads, which could miss cardiac ischemia in other cardiac regions. Further studies are needed to verify if the watch could yield valuable diagnostic information. CONCLUSIONThis article reveals a novel use of the Apple Watch 4 to obtain a 3-lead ECG. Adjustments to its software might yield the capability to obtain the augmented limb leads generating a 6-lead ECG. The watch has already received clearance from the US Food and Drug Administration for detection of atrial fibrillation13 and the novel technique described here could expand its function. This additional function of the watch may serve to implement a low-cost but high-value method of patient empowerment in the earlier detection of acute coronary artery disease. Disclosure StatementThe author(s) have no conflicts of interest to disclose. AcknowledgmentsKathleen Louden, ELS, of Louden Health Communications performed a primary copy edit. How to Cite this ArticleAvila CO. Novel use of Apple Watch 4 to obtain 3-lead electrocardiogram and detect cardiac ischemia. Perm J 2019;23:19-025. DOI: https://doi.org/10.7812/TPP/19-025 Author Affiliations1 Department of Emergency Medicine, San Diego Medical Center, CA Corresponding AuthorCesar O Avila, MD (cesar.o.avila@kp.org) References1. Multiple cause of death files, 1999-2013, CDC WONDER [Internet]. Atlanta, GA: Centers for Disease Control and Prevention [cited 2015 Feb 3]. Available from: https://wonder.cdc.gov/mcd.html.
|
ETOC
Click here to join the eTOC list or text ETOC to 22828. You will receive an email notice with the Table of Contents of The Permanente Journal.
CIRCULATION
2 million page views of TPJ articles in PubMed from a broad international readership.
Indexing
Indexed in MEDLINE, PubMed Central, EMBASE, EBSCO Academic Search Complete, and CrossRef.